COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
Thomas Chatzikonstantinou(G. Papanikolaou General Hospital), Elżbieta Kalicińska(The University of Melbourne), Odit Gutwein(Assaf Harofeh Medical Center), D. Donaldson(University of St Andrews), Christos Demosthenous(G. Papanikolaou General Hospital), Yervand Hakobyan, Massimo Gentile(Azienda Ospedaliera di Cosenza), Lorenzo De Paoli(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Henrik Frederiksen(University of Southern Denmark), Giovanni Del Poeta(University of Rome Tor Vergata), David Allsup(University of Leeds), María Gomes da Silva(Instituto Português de Oncologia Francisco Gentil), Rocío García‐Serra(Hospital General Universitario De Valencia), Lydia Scarfò(IRCCS Ospedale San Raffaele), Shaimaa El‐Ashwah(Mansoura University), Maria Dimou(National and Kapodistrian University of Athens), Panagiotis Baliakas(Uppsala University), Darko Antić(University of Belgrade), Lucia Farina(Fondazione IRCCS Istituto Nazionale dei Tumori), Juan Gonzalo Correa(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), José‐Ángel Hernández‐Rivas(Hospital Universitario Infanta Leonor), Michael Doubek(Central European Institute of Technology), Anargyros Kapetanakis(Centre for Research and Technology Hellas), Idanna Innocenti(Università Cattolica del Sacro Cuore), Gilad Itchaki(Meir Medical Center), Mónica Baile(Instituto de Investigación Biomédica de Salamanca), Alicia Enrico(Hospital Italiano La Plata), Alejandro Alonso Cabrero(Hospital Universitario de La Princesa), Olga Kalashnikova(First Pavlov State Medical University of St. Petersburg), Blanca Espinet(Hospital Del Mar), Carolina Cuéllar‐García(Hospital Terrassa), Moritz Fürstenau(University of Cologne), Eva Gimeno(Hospital Del Mar), Ann Janssens, Maria Rosaria De Paolis(Istituto Nazionale di Fisica Nucleare, Sezione di Lecce), Sofia Chatzileontiadou(AHEPA University Hospital), Raúl Córdoba(Hospital Universitario Fundación Jiménez Díaz), Martin Andres(University of Bern), Ozren Jakšić(University of Zagreb), Maria Efstathopoulou(Mansoura University), José A. García‐Marco(Hospital Universitario Puerta de Hierro Majadahonda), Tobias Herold(German Cancer Research Center), Andreas Glenthøj(University of Copenhagen), Barbara Eichhorst(University of Cologne), Angela Ferrari(Santa Maria Nuova Hospital), Dominique Bron, Yair Herishanu(Tel Aviv University), Myriam Foglietta(Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo), Antonella Capasso(IRCCS Ospedale San Raffaele), Georgios Karakatsoulis(University of Ioannina)
Cited by 94
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
|Blood|2018|1.7k
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k
Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2018|907